NU:NYSE

Nu Holdings Ltd.

Data as of 2026-03-10 - not real-time

$14.67

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Nu Holdings is trading near a key support level with the Relative Strength Index in the low‑30s, suggesting the stock may be oversold, while the MACD remains bearish, indicating continued downside pressure in the short term. Fundamentally, the company delivers strong revenue growth and robust operating margins, yet its trailing P/E sits well above the industry average, pointing to a premium valuation. The forward P/E, however, is considerably lower, implying that earnings are expected to accelerate and the current price may be more justified on a forward basis. Volatility is elevated, and beta exceeds one, reflecting heightened sensitivity to market swings, especially given the regional banking sector’s exposure to economic cycles. Despite these headwinds, the balance sheet shows ample cash relative to debt, and the analyst consensus is overwhelmingly positive with a strong‑buy rating.
The upside potential estimated by analysts exceeds 30%, while the market sentiment index signals extreme greed, indicating strong investor appetite. The combination of a solid growth narrative, improving earnings outlook, and attractive upside suggests that the stock could rebound if technical pressures ease, making it a compelling candidate for investors with a medium‑to‑long horizon.

Trading Recommendations

Short Term

< 1 year
hold
Conviction: 7/10

Key Factors

  • Oversold RSI indicating potential near‑term bounce
  • Bearish MACD signaling continued downside risk
  • Proximity to technical support level

Medium Term

1–3 years
buy
Conviction: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • Forward P/E discount relative to trailing valuation
  • Analyst consensus of strong‑buy and sizable upside estimate

Long Term

> 3 years
buy
Conviction: 9/10

Key Factors

  • Robust cash position and manageable debt profile
  • Expanding digital banking footprint across Latin America and the U.S.
  • Sustained earnings growth potential underpinning long‑term value

Key Metrics & Analysis

Financial Health

Revenue Growth43.90%
Profit Margin41.04%
P/E Ratio24.9
ROE30.28%
ROA4.60%
P/B Ratio6.3
Op. Cash Flow$-9360818176
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI33.0
Support$14.17
Resistance$17.99
MA 20$16.18
MA 50$16.92
MA 200$15.08
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Target Price$20.17
Upside/Downside37.51%
GradeFair
TypeBlend

Risk Assessment

Beta1.14
Volatility49.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.